Atıf Formatları
Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

I. E. Demir Et Al. , "Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer," EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1, pp.1-3, 2017

Demir, I. E. Et Al. 2017. Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer. EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1 , 1-3.

Demir, I. E., Ceyhan, G. O., & Friess, H., (2017). Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer. EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1, 1-3.

Demir, Ihsan, GÜRALP ONUR CEYHAN, And Helmut Friess. "Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer," EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1, 1-3, 2017

Demir, Ihsan E. Et Al. "Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer." EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1, pp.1-3, 2017

Demir, I. E. Ceyhan, G. O. And Friess, H. (2017) . "Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer." EXPERT OPINION ON THERAPEUTIC TARGETS , vol.21, no.1, pp.1-3.

@article{article, author={Ihsan Ekin Demir Et Al. }, title={Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer}, journal={EXPERT OPINION ON THERAPEUTIC TARGETS}, year=2017, pages={1-3} }